About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 116 record(s)
Req # A-2022-000432
All ventilation and/or building air filtration records from Health Canada's Occupational Health and Safety (OHS) division, from March 1, 2020 to June 30, 2022.Organization: Health Canada
August 2022
Req # A-2022-000462
Contracted studies, internal documents, reports and statistics by Canadian Research Initiative in Substance Misuse (CRISM) regarding addiction treatment and opioid agonist treatment (OAT) and any contribution to policy changes regarding addiction treatment and opioid agonist treatment from May 2018 to July 8, 2022.Organization: Health Canada
August 2022
Req # A-2022-000483
Data and reports that were commissioned by Health Canada to understand Canadian perceptions regarding Cannabis use and specific product formats such as vapes. The reports should stem from 2018 to July 12, 2022.Organization: Health Canada
August 2022
Req # A-2022-000493
Details of any proceedings, claims or appeals currently active or in progress or pending or any balance due to you from these Companies. TEMPLE LIFESTYLE INCORPORATED NEQ: 1166436049 and TEMPLE LIFESTYLE BRANDS INC. NEQ: 1171680177.Organization: Health Canada
August 2022
Req # A-2022-000520
All safety data for the health effects of electric cars on our environment. Safety data for power charging stations for electric cars. All data for the effects of these charging stations. Data on the effects of lithium mining to make the batteries. All data on lithium safety for Canadians.Organization: Health Canada
August 2022
Req # A-2022-000534
For the purpose of conducting a due diligence examination of the company Iris Performance Inc. IRIS PERFORMANCE INC (NEQ: 1172774284) (NE: 714734324), whose head office is located at 3565 rue Fernand-Flipot in Longueuil, province of Quebec, J3Y 0M7, and whose place of business is located at 1450 Boulevard Lionel-Boulet in Varennes, province of Quebec, J3X 1P7. Any information you have regarding the Company or confirmation that the Company is in good standing with your organization.Organization: Health Canada
August 2022
Req # A-2022-000567
Reports or briefings discussing mass shootings as a public health crisis considering treatment and prevention through the use of public health measures. Limited to or from director level and above. January 1, 2020 to August 8, 2022.Organization: Health Canada
August 2022
Req # A-2022-000568
Reports or briefings discussing national security risks posed by underfunding of mental healthcare services. Limited to or from director level and above. January 1, 2020 to August 8, 2022.Organization: Health Canada
August 2022
Req # A-2017-001468
Adverse Drug Reactions (ADRs) for PANTOPRAZOLE SODIUM. Report numbers: E2B_01380857, E2B_01387851, E2B_01393344, E2B_01393381, E2B_01393401, E2B_01393424, E2B_01393430, E2B_01397498, E2B_01399399, E2B_01399517, E2B_01399528, E2B_01399543, E2B_01399552, E2B_01401642, E2B_01401647, E2B_01401654, E2B_01403779, E2B_01403781, E2B_01403783, E2B_01403792, E2B_01403794, E2B_01405655, E2B_01405659, E2B_01405663, E2B_01407198, E2B_01407879, E2B_01412413, E2B_01412727, E2B_01415415, E2B_01416813.Organization: Health Canada
August 2022
Req # A-2019-001878
Adverse Drug Reactions (ADRs) for NICODERM. Report numbers: 000082489, 000082490, 000082762, 000124742, 000142959,000149041, 000162584, 000167061,000168635, 000176829, 000179810, 000180288, 000183685, 000184306, 000193630, 000214690, 000222530, 000226480, 000305248, 000311145, 000329610, 000354382, 000356000, 000392031, 000466455, 000632284, 000673373, 000673375, 000715107.Organization: Health Canada
August 2022